Efficient Analysis of Hepatic Glucose Output and Insulin Action Using a Liver Slice Culture System

Abstract

Background: Liver slices have been reported to retain histological integrity and metabolic capacity for over 24 hours in flask culture systems, and they have been used for pharmacological and toxicological studies before. However, whether this method is suitable to measure hepatic glucose output is unknown. Methods: Precision-cut liver slices were prepared from fresh male rat liver. After high-glucose pre-incubation (11.2 mmol/l), medium was changed to low-glucose conditions (0.5 mmol/l). Glucose and lactate levels as well as aspartate aminotransferase activity were monitored for 50 minutes with or without addition of insulin (600 pmol/l) and/or epinephrine (0.5 µmol/l). Slice potassium content and histology were examined to prove liver viability. Results: We observed a stable glucose production from the liver slices of 0.3 - 0.4 µmol/g liver/min. Epinephrine increased (by 82 ± 30 %) and insulin decreased (by 80 ± 8 %) liver slice glucose output. Significant signs of ischemia were not detected. Conclusions: Hepatic glucose release can be reliably measured in a liver slice culture system, and it is regulated by major hormone systems. This method may be helpful for further characterization of direct insulin action and resistance in a complex tissue as the liver; however, pharmacological applications such as the analysis of drug effects on hepatic glucose metabolism can also be envisioned.

Key words

Hepatic glucose output - Liver slice culture - Insulin - Epinephrine

References

• 1 Roden M, Bernroider E. Hepatic glucose metabolism in humans - its role in health and disease.  Best Pract Res Clin Endocrinol Metab. 2003;  17 365-383
• 2 Prager R, Wallace P, Olefsky J M. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.  Diabetes. 1987;  36 607-611
• 3 Consoli A. Role of liver in pathophysiology of NIDDM.  Diabetes Care. 1992;  15 430-441
• 4 Garcia-Estevez D A, Araujo-Vilar D, Fiestras-Janeiro G, Saavedra-Gonzalez A, Cabezas-Cerrato J. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices.  Horm Metab Res. 2003;  35 13-17
• 5 Seppala-Lindroos A, Vehkavaara S, Hakkinen A M, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.  J Clin Endocrinol Metab. 2002;  87 3023-3028
• 6 Buettner R, Ottinger I, Scholmerich J, Bollheimer L C. Preserved direct hepatic insulin action in diet-induced hepatic steatosis.  Am J Physiol Endocrinol Metab. 2004;  286 E828-E833
• 7 Harris R B, Kor H. Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30 % of energy.  J Nutr. 1992;  122 1811-1822
• 8 Barzilai N, She L, Liu B Q, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance.  Diabetes. 1999;  48 94-98
• 9 Obici S, Zhang B B, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production.  Nat Med. 2002;  8 1376-1382
• 10 Cheung K, Hickman P E, Potter J M, Walker N I, Jericho M, Haslam R, Roberts M S. An optimized model for rat liver perfusion studies.  J Surg Res. 1996;  66 81-89
• 11 Leffert H, Moran T, Sell S, Skelly H, Ibsen K, Mueller M, Arias I. Growth state-dependent phenotypes of adult hepatocytes in primary monolayer culture.  Proc Natl Acad Sci U S A. 1978;  75 1834-1838
• 12 Bissell D M, Guzelian P S. Phenotypic stability of adult rat hepatocytes in primary monolayer culture.  Ann N Y Acad Sci. 1980;  349 85-98
• 13 Straub R H, Pongratz G, Gunzler C, Michna A, Baier S, Kees F, Falk W, Scholmerich J. Immunoregulation of IL-6 secretion by endogenous and exogenous adenosine and by exogenous purinergic agonists in splenic tissue slices.  J Neuroimmunol. 2002;  125 73-81
• 14 Olinga P, Groen K, Hof I H, de Kanter R, Koster H J, Leeman W R, Rutten A A, van Twillert K, Groothuis G M. Comparison of five incubation systems for rat liver slices using functional and viability parameters.  J Pharmacol Toxicol Methods. 1997;  38 59-69
• 15 Parrish A R, Gandolfi A J, Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology.  Life Sci. 1995;  57 1887-1901
• 16 Olinga P, Hof I H, Merema M T, Smit M, De Jager M H, Swart P J, Slooff M J, Meijer D K, Groothuis G M. The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake.  J Pharmacol Toxicol Methods. 2001;  45 55-63
• 17 McKee R L, Hruby V J, Trivedi D B, Johnson D G, Gandolfi A J, Krumdieck C L, Brendel K. Perifused precision-cut liver slice system for the study of hormone-regulated hepatic glucose metabolism.  J Pharmacol Methods. 1988;  19 339-354
• 18 Hems D A, Rodrigues L M, Whitton P D. Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II.  Biochem J. 1976;  160 367-374
• 19 Englisch R, Wurzinger R, Furnsinn C, Schneider B, Frisch H, Waldhausl W, Graf J, Roden M. Effects of insulin-like growth factor I on basal and stimulated glucose fluxes in rat liver.  Biochem J. 2000;  351 39-45
• 20 Chu C A, Sindelar D K, Neal D W, Allen E J, Donahue E P, Cherrington A D. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.  J Clin Invest. 1997;  99 1044-1056
• 21 Lam T K, Carpentier A, Lewis G F, van de W G, Fantus I G, Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production.  Am J Physiol Endocrinol Metab. 2003;  284 E863-E873
• 22 Rossetti L, Massillon D, Barzilai N, Vuguin P, Chen W, Hawkins M, Wu J, Wang J. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.  J Biol Chem. 1997;  272 27 758-27 763
• 23 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn B B, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.  Nat Med. 2002;  8 1288-1295
• 24 Rajala M W, Obici S, Scherer P E, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.  J Clin Invest. 2003;  111 225-230